MedTrace Logo

Collagen Peptide Supplementation and Lifelong Athletes

NCT05751005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2023-03-02

No results posted yet for this study

Summary

The aim of the current research is to evaluate the effects of 6 and 9 months of Solugel® supplementation on joint mobility, comfort, performance, body composition and related biomarkers of joint and bone health in older life-long athletes and physically active people. Doses of zero, 10, and 20 g per day for 6 or 9 months will be administered to determine, if any, is most effective at improving the previously mentioned outcomes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Collagen Peptides vs. Placebo

Participants were randomized into one of three treatment groups.

Sponsors & Collaborators

  • Tessenderlo Group

    collaborator UNKNOWN

  • Florida State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-29
Primary Completion
2020-05-28
Completion
2022-04-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05751005 on ClinicalTrials.gov